Naltrexone And Bupropion
Pharmacological and Behavioral Treatment After Bariatric Surgery: Acute (Stage 1)
Orexigen Therapeutics, Inc · Phase 2/3 · Completed · Enrollment 92
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Behavioral Weight Loss (BWL) + Naltrexone and Bupropion (NB) medication | Obesity or overweight | n/r | 16 | n/r | n/r |
| BWL + Placebo | Obesity or overweight | n/r | 16 | n/r | n/r |
| NB medication | Obesity or overweight | n/r | 16 | n/r | n/r |
| Placebo | Obesity or overweight | n/r | 16 | n/r | n/r |